Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-23-008571)

Filing Details

Accession Number:: 0001562180-23-008571
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2023-12-28 16:38:37
Reporting Period:: 2023-12-26

Accepted Time:: 2023-12-28 16:38:37
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1710072	Edgewise Therapeutics Inc.	EWTX	Pharmaceutical Preparations (2834)	821725586

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1853529	J Alan Russell	C/O Edgewise Therapeutics, Inc. 1715 38Th Street Boulder CO 80301	Chief Scientific Officer	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2023-12-26	172,585	$9.33	3,606	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $9.155 USD to $9.595 USD; the price reported above reflects the weighted average sale price.